ImmunoScape is thrilled to announce its collaboration with Johns Hopkins University/NIAID to deeply profile the SARS-CoV-2-specific CD8 T cell response in COVID-19 recovered donors. Gaining insights into T cells that interact with specific regions of the SARS-CoV-2...
ImmunoScape won Singapore’s most prestigious Emerging Enterprise Award organized by Business Times and OCBC Bank. Emerging Enterprise Award honors the bold ambition of Singapore’s young businesses. It is a celebration of business innovation, resilience and...
Please join our oral presentation on, “Broad and Prevalent SARS-CoV-2 CD8+ T Cell Response in Recovered COVID-19 Individuals Demonstrates Kinetics of Early Differentiation” and meet our team. Session Date: Tuesday, December 1, 2020 Session Time: 4:20 PM...
This webinar will focus on how ImmunoScape used high-dimensional, mass cytometry-based immunophenotyping of circulating lymphocytes to compare phenotypic expression across patients and timepoints, and correlate these with post-RT tumor responses. An expansion in...
In the fight against COVID-19, ImmunoScape is joining forces with Dr. Patrick Reeves, Team Leader at the Massachusetts General Hospital Vaccine & Immunotherapy Center, using its signature assay, TargetScape, to perform high-dimensional immune profiling of COVID-19...
